EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0QCO: Pharming Group N.V.

19 Dec 2025
LAST:

1.373

CHANGE:
 0.02		OPEN:
1.385		HIGH:
1.399		ASK:
0.771		VOLUME:
31.5K
CHG(%):
1.08		PREV:
1.388		LOW:
1.367		BID:
0.734		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Dec 251.3851.3991.3671.37331.5K
18 Dec 251.3851.4031.3791.38898.0K
17 Dec 251.3891.4351.3751.392153.7K
16 Dec 251.4101.4221.3831.394429.2K
15 Dec 251.5051.5051.4251.429300.3K
12 Dec 251.4851.4851.4641.47429.8K
11 Dec 251.4661.4891.4291.463169.8K
10 Dec 251.4541.4781.4431.464141.3K
09 Dec 251.4561.4611.4331.459204.2K
08 Dec 251.4301.4611.4261.447140.2K

PROFILE

Name:Pharming Group N.V.
About:Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. It has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Address:Darwinweg 24, Leiden, Netherlands, 2333 CR
Website:https://www.pharming.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:57.03 
Price to Sales:4.29 
Price to Book:3.71 
Profit Margin:-0.08 
Operating Margin:-0.13 
Return on Assets:-0.04 
Return on Equity:-0.08 
EPS Ratio:0.02 
Revenue:179.05M 
EBITDA:12.47M 
Shares:638.56M 
Market Cap:876.74M 

TECHNICAL INDICATORS

MA5:1.401.6%
MA10:1.434.0%
MA20:1.434.1%
MA50:1.332.9%
MA100:1.269.3%
MA200:1.0629.9%
STO14:10.81 
RSI14:48.16
WPR14:-86.32 
MTM14:0.00
ROC14:0.00 
ATR:0.05 
Week High:1.519.6%
Week Low:1.370.4%
Month High:1.5311.1%
Month Low:1.3429.9%
Year High:1.5311.1%
Year Low:0.66108.8%
Volatility:41.81 

RECENT SPLITS

Date Ratio
23 Nov 2016805-799
05 Mar 20131-10